Evidence map›Paper›PMID 30039785›Full record

ArticleThe American journal of tropical medicine and hygiene2018

Epidemiology of Severe Acute Respiratory Illness and Risk Factors for Influenza Infection and Clinical Severity among Adults in Malawi, 2011-2013.

Antonia Ho, Jane Mallewa, Ingrid Peterson, Miguel SanJoaquin, Shikha Garg, Naor Bar-Zeev, Mavis Menyere, Maaike Alaerts, Gugulethu Mapurisa, Moses Chilombe and 8 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Antonia HoInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Jane MallewaDepartment of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Ingrid PetersonMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Miguel SanJoaquinWorld Bank, Phnom Penh, Cambodia.
Shikha GargInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Naor Bar-ZeevJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Mavis MenyereMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Maaike AlaertsMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Gugulethu MapurisaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Moses ChilombeMalawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Mulinda NyirendaDepartment of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
David G LallooLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Camilla RotheDivision of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.
Marc-Alain WiddowsonDivision of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia.
Meredith McMorrowInfluenza Division, Centers for Disease Control and Prevention, Pretoria, South Africa.
Neil FrenchInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Dean EverettUniversity of Edinburgh, Edinburgh, United Kingdom.
Robert S HeydermanDivision of Infection and Immunity, University College London, London, United Kingdom.

Funding

Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory InfectU01IP000848 · IP · UNIVERSITY OF LIVERPOOL · PI FRENCH, NEIL · 2014 to 2018
$4.3M
Medical Research Council MC_UU_12014/9NCIRD CDC HHS U01 IP000848Wellcome Trust 091947
6 · The paper itself

Abstract

Data on the epidemiology of severe acute respiratory illness (SARI) in adults from low-income, high human immunodeficiency virus (HIV) prevalence African settings are scarce. We conducted adult SARI surveillance in Blantyre, Malawi. From January 2011 to December 2013, individuals aged ≥ 15 years with SARI (both inpatients and outpatients) were enrolled at a large teaching hospital in Blantyre, Malawi. Nasopharyngeal aspirates were tested for influenza and other respiratory viruses by polymerase chain reaction. We estimated hospital-attended influenza-positive SARI incidence rates and assessed factors associated with influenza positivity and clinical severity (Modified Early Warning Score > 4). We enrolled 1,126 SARI cases; 163 (14.5%) were positive for influenza. Human immunodeficiency virus prevalence was 50.3%. Annual incidence of hospital-attended influenza-associated SARI was 9.7-16.8 cases per 100,000 population. Human immunodeficiency virus was associated with a 5-fold greater incidence (incidence rate ratio 4.91, 95% confidence interval [CI]: 3.83-6.32). On multivariable analysis, female gender, as well as recruitment in hot, rainy season (December to March; adjusted odds ratios (aOR): 2.82, 95% CI: 1.57-5.06) and cool, dry season (April to August; aOR: 2.47, 95% CI: 1.35-4.15), was associated with influenza positivity, whereas influenza-positive patients were less likely to be HIV-infected (aOR: 0.59, 95% CI: 0.43-0.80) or have viral coinfection (aOR: 0.51, 95% CI: 0.36-0.73). Human immunodeficiency virus infection (aOR: 1.86; 95% CI: 1.35-2.56) and recruitment in hot, rainy season (aOR: 4.98, 95% CI: 3.17-7.81) were independently associated with clinical severity. In this high HIV prevalence population, influenza was associated with nearly 15% of hospital-attended SARI. Human immunodeficiency virus infection is an important risk factor for clinical severity in all-cause and influenza-associated SARI. Expanded access to HIV testing and antiretroviral treatment, as well as targeted influenza vaccination, may reduce the burden of SARI in Malawi and other high HIV prevalence settings.

Indexed as

AdolescentAdultFemaleHIV InfectionsHumansIncidenceInfluenza, HumanMalawiMaleMiddle AgedOdds RatioPopulation SurveillancePovertyRisk FactorsSeasonsYoung Adult

Identifiers

PMID30039785
PMCPMC6169174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.